鄭州銀行(06196.HK)成功發行50億元創新創業金融債券
格隆匯8月24日丨鄭州銀行(06196.HK)發佈公吿,經銀保監會河南監管局和中國人民銀行核准,該行近日在全國銀行間債券市場成功發行“鄭州銀行股份有限公司2021年創新創業金融債券”。本次債券於2021年8月19日簿記建檔,並於2021年8月23日發行完畢,發行規模為人民幣50億元,品種為3年期固定利率債券,票面利率為3.16%。根據相關法律法規及監管要求,本次債券募集的資金將專項用於創新創業領域信貸投放。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.